Real-World study reveals how anesthesia reversal drug is actually used

NCT ID NCT05788718

Completed Knowledge-focused Sponsor: Boryung Pharmaceutical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study observed over 6,400 adults undergoing elective surgery to see how doctors prescribe sugammadex, a drug that reverses muscle paralysis from anesthesia. Researchers collected data from routine care, without extra tests or treatments. The goal was to understand prescription patterns and check the drug's safety and effectiveness in everyday hospital settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Sugammadex
What this could lead to: If successful, this study could confirm that sugammadex is used safely and effectively in everyday medical practice, helping doctors make better decisions.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by factors like patient differences or doctor choices.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANESTHESIA NEUROMUSCULAR BLOCKADE POSTOPERATIVE COMPLICATIONS

Contacts and locations

Show contact details

Locations

Korea University Anam Hospital

Seoul, Seongbuk-gu, 02841, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.